Education
About Us
Working with TipRanks
Follow Us
Joshua Disbrow Insider Profile
4 Followers
Joshua Disbrow, COO at Ampio Pharmaceuticals, holds 0.00 shares in Ampio Pharmaceuticals (Ticker: AMPE), holds 153.26K shares in Aytu BioScience (Ticker: AYTU), holds 22.50K shares in Zynex (Ticker: ZYXI). Most recently, Joshua Disbrow ― shares of Ampio Pharmaceuticals on ― for an estimated value of ―.
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
-6.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Joshua Disbrow holds in companies
Most Profitable Insider Trade
The most profitable trade made by Joshua Disbrow
Joshua Disbrow's Trading History
Ampio Pharmaceuticals
―
COO
―
$0.00
Aytu BioScience
Jun 10, 2025
CEO
Informative Buy
100.00K
$363.22K
Zynex
May 16, 2025
Director
Uninformative Buy
―
$32.63K
List of latest transactions for each holding click on a transaction to see Joshua Disbrow's performance on stock
You May Also Like
Joshua Disbrow insider profile FAQ
What is the percentage of profitable transactions made by Joshua Disbrow?
The percentage of profitable transactions made by Joshua Disbrow is 43%.
What is the average return per transaction made by Joshua Disbrow?
The average return per transaction made by Joshua Disbrow is -6.50%.
What stocks does Joshua Disbrow hold?
Joshua Disbrow holds: AMPE, AYTU, ZYXI stocks.
What was Joshua Disbrow’s latest transaction?
Joshua Disbrow latest transaction was an Uninformative Buy of ―.
What was Joshua Disbrow's most profitable transaction?
Joshua Disbrow’s most profitable transaction was an Informative Buy of AYTU stock on March 3, 2025. The return on the trade was 88.00%.
What is Joshua Disbrow's role in Ampio Pharmaceuticals?
Joshua Disbrow's role in Ampio Pharmaceuticals is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.